Emecad 0.25mg Injection
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Palonosetron (0.25mg)
Overview Emecad 0.25mg Injection
Ondansetron 0.25mg Injection is an antiemetic medication frequently administered to manage nausea and vomiting stemming from various medical issues, including gastrointestinal distress. It's also employed to prevent nausea and vomiting resulting from surgery, chemotherapy, or radiation therapy. This medication does not alleviate other adverse effects linked to cancer treatment. Administered under medical supervision, it can be used independently or in conjunction with other therapies. Dosage is determined by your physician based on your specific needs. Continue injections as directed; cessation should only occur under your doctor's guidance. Following treatment, oral medication may be substituted. Common side effects include injection site discomfort, headache, and constipation. Dizziness and drowsiness may also occur; avoid driving or activities requiring alertness until effects are known. These effects typically subside upon discontinuation. Persistent or bothersome side effects warrant medical consultation for potential mitigation strategies. Prior to use, inform your physician of any pre-existing heart or liver conditions, bowel obstructions, or concurrent medications, particularly those for epilepsy, cardiac issues, cancer, or depression, as interactions may occur. Pregnant or breastfeeding individuals should seek medical counsel.
Primary Ingredients of Emecad 0.25mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Emecad 0.25mg Injection
Sickness to the stomach | Emesis
Major Benefits of Emecad 0.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Emecad 0.25mg Injection:
- Injection site pain
- Constipation
- Headache
- Diarrhea
- Dizziness
How to use Emecad 0.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Emecad 0.25mg Injection works:
Nausin 0.25mg Injection, an anti-nausea drug, counteracts the effects of serotonin, a neurotransmitter implicated in chemotherapy- and post-surgical-induced nausea and vomiting.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption alongside Emecad 0.25mg Injection is undetermined. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable form of Emecad (0.25mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; however, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Emecad 0.25mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
The administration of Emecad 0.25mg Injection can potentially reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if any of these effects manifest.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Emecad 0.25mg Injection is considered safe and requires no dosage modification.
LiverSAFE IF PRESCRIBED
Emecad 0.25mg Injection presents no safety concerns for patients with hepatic impairment; dosage modification is unnecessary.
What if you forget to take Emecad 0.25mg Injection :
Should you forget a scheduled Emecad 0.25mg Injection, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Emecad 0.25mg Injection
| Label | Value |
|---|---|
| Chemical Category | Isoquinoline and Quinuclidine Derivatives |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | 5-HT3 receptor blockers |
3,018 People bought this recently